• 1
    De La Rosa A, Williams RL, Steeg PS. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 1995; 17: 5362.
  • 2
    Min K, Kim SY, Song, HK, Chang C, Cho SJ, Moon J, Yang JK, Lee JY, Lee KJ, Suh SW. Crystallization and preliminary X-ray crystallographic analysis of human nucleoside diphosphate kinase A. Acta Crystallogr D Biol Crystallogr 2000; D56:503504.
  • 3
    Morera S, Lacombe ML, Xu Y, Lebras G, Janin J. X-ray structure of human nucleoside diphosphate kinase B complexed with GDP at 2 Å resolution. Structure 1995; 3: 13071314.
  • 4
    Webb PA, Perisic O, Mendola CE, Backer JM, Williams RL. The crystal structure of a human nucleoside diphosphate kinase, NM23-H2. J Mol Biol 1995; 251: 574587.
  • 5
    MacDonald NJ, Freije JMP, Stracke ML, Manrow RE, Steeg PS. Site-directed mutagenesis of Nm23-H1: mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells. J Biol Chem 1996; 271: 2510725116.
  • 6
    Wagner PD, Steeg PS, Vu ND. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci USA 1997; 94: 90009005.
  • 7
    Chang CL, Strahler JL, Thoraval DH, Qian MG, Hinderer R, Hanash SM. A nucleoside diphosphate kinase A (nm23-H1) serine 120 → glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction. Oncogene 1996; 12: 659667.
  • 8
    Lascu I, Chaffotte A, Limbourg-Bouchon B, Veron M. A Pro/Ser substitution in nucleoside diphosphate kinase of Drosophila melanogaster (mutation killer of prune) affects stability but not catalytic efficiency of the enzyme. J Biol Chem 1992; 267: 1277512781.